Allison Dorval
CIK 1625110 · Chief Financial Officer · last filed 2025-07-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.54M
Companies
5
Total Filings
33
Lifetime Open-Market Net
-$237.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) Delisted | Chief Financial Officer | 0 | $11.13 | $0 | -$35.6K | 10 | 2025-07-28 |
| PBYI | Director | 75,390 | $7.33 | $552.6K | -$111.1K | 7 | 2025-06-17 |
| Jade Biosciences, Inc. (AVTE) Delisted | Director | — | $93.80 | — | $0 | 4 | 2024-06-07 |
| VYGR | Chief Financial Officer | 109,894 | $3.50 | $384.6K | -$91.2K | 8 | 2021-03-23 |
| PODD | Chief Financial Officer | 37,415 | $149.70 | $5.60M | $0 | 4 | 2015-04-03 |
Recent Filings · Page 2 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-01 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +1,321 | -$6.3K | EDGAR |
| 2023-06-15 | PBYI | Mixed | +17,000 | -$34.5K | EDGAR |
| 2023-06-08 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-16 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-01 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +1,321 | -$12.2K | EDGAR |
| 2022-06-22 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | PBYI | Grant (A) | +27,000 | $0 | EDGAR |
| 2022-02-15 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-30 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-19 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.